[go: up one dir, main page]

AR041090A1 - Uso de toxina labil al calor de esterichia coli como adyuvante en pajaros y aves de corral - Google Patents

Uso de toxina labil al calor de esterichia coli como adyuvante en pajaros y aves de corral

Info

Publication number
AR041090A1
AR041090A1 ARP030103129A ARP030103129A AR041090A1 AR 041090 A1 AR041090 A1 AR 041090A1 AR P030103129 A ARP030103129 A AR P030103129A AR P030103129 A ARP030103129 A AR P030103129A AR 041090 A1 AR041090 A1 AR 041090A1
Authority
AR
Argentina
Prior art keywords
birds
heat
assistant
corral
toxin
Prior art date
Application number
ARP030103129A
Other languages
English (en)
Original Assignee
Dow Agrosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Agrosciences Llc filed Critical Dow Agrosciences Llc
Publication of AR041090A1 publication Critical patent/AR041090A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se refiere a composiciones y métodos para utilizar la toxina lábil al calor de E. coli (TL) y sus análogos como adyuvantes en aves. Además describe composiciones y métodos pata utilizar TL producida por plantas, sus análogos conocidos y los inmunógenos protectores como vacunas en aves.
ARP030103129A 2002-08-27 2003-08-28 Uso de toxina labil al calor de esterichia coli como adyuvante en pajaros y aves de corral AR041090A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40635902P 2002-08-27 2002-08-27

Publications (1)

Publication Number Publication Date
AR041090A1 true AR041090A1 (es) 2005-05-04

Family

ID=31978291

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030103129A AR041090A1 (es) 2002-08-27 2003-08-28 Uso de toxina labil al calor de esterichia coli como adyuvante en pajaros y aves de corral

Country Status (12)

Country Link
US (1) US20040146533A1 (es)
EP (1) EP1551451B1 (es)
JP (1) JP2005539039A (es)
CN (1) CN100435844C (es)
AR (1) AR041090A1 (es)
AT (1) ATE423569T1 (es)
AU (1) AU2003274925A1 (es)
BR (1) BR0314088A (es)
CA (1) CA2491568A1 (es)
DE (1) DE60326369D1 (es)
ES (1) ES2320119T3 (es)
WO (1) WO2004020585A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100387719C (zh) * 2005-05-09 2008-05-14 中国农业科学院生物技术研究所 编码大肠杆菌热敏毒素基因及其表达载体和用途
RU2561673C2 (ru) * 2006-03-30 2015-08-27 Эмбрекс, Инк. Способы и композиции для вакцинации домашней птицы
US8202967B2 (en) 2006-10-27 2012-06-19 Boehringer Ingelheim Vetmedica, Inc. H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
EP2329845A4 (en) * 2008-08-18 2013-08-14 Kitasato Daiichi Sankyo Vaccine Co Ltd BIRD GRAPEVIRUS ANTIGEN AND BOOSTER IMMUNIZATION PROCEDURE FOR BIRD FLUID VACCINE IN COMBINATION WITH A MUCOSAL ADJUVAN WITH EFFICACY THROUGH ORAL ADMINISTRATION
KR20120101572A (ko) * 2009-12-28 2012-09-13 메리얼 리미티드 재조합 ndv 항원 및 이의 용도
AR088028A1 (es) 2011-08-15 2014-05-07 Boehringer Ingelheim Vetmed Proteinas h5, de h5n1 para un uso medicinal

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002484A1 (en) * 1988-09-06 1990-03-22 Washington University Oral immunization by transgenic plants
IT1253009B (it) * 1991-12-31 1995-07-10 Sclavo Ricerca S R L Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
US6019982A (en) * 1994-08-26 2000-02-01 The Administrators Of The Tulane Educational Fund Mutant enterotoxin effective as a non-toxic oral adjuvant
ES2235176T3 (es) * 1994-10-24 2005-07-01 THE TEXAS A & M UNIVERSITY SYSTEM Inmunizacion oral con plantas transgenicas.
US6395964B1 (en) * 1995-10-24 2002-05-28 The Texas A&M University System Oral immunization with transgenic plants
JP2002533068A (ja) * 1998-12-22 2002-10-08 ボイス トンプソン インスティテュート フォア プラント リサーチ トランスジェニック植物に発現される経口で免疫原性の細菌エンテロトキシン

Also Published As

Publication number Publication date
AU2003274925A8 (en) 2004-03-19
US20040146533A1 (en) 2004-07-29
AU2003274925A1 (en) 2004-03-19
CN100435844C (zh) 2008-11-26
WO2004020585A3 (en) 2004-08-12
CN1678343A (zh) 2005-10-05
BR0314088A (pt) 2005-07-19
WO2004020585A2 (en) 2004-03-11
DE60326369D1 (de) 2009-04-09
EP1551451A4 (en) 2005-11-16
JP2005539039A (ja) 2005-12-22
WO2004020585B1 (en) 2004-10-07
EP1551451A2 (en) 2005-07-13
CA2491568A1 (en) 2004-03-11
ATE423569T1 (de) 2009-03-15
EP1551451B1 (en) 2009-02-25
ES2320119T3 (es) 2009-05-19

Similar Documents

Publication Publication Date Title
PA8617701A1 (es) Nuevos compuestos farmaceuticos
ECSP088225A (es) 1h-imidazopiridinas sustituidas con hidroxi y procedimientos
CR8254A (es) [1,8] naftidrin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia
PA8609201A1 (es) Piridinonas sustituidas
UY28680A1 (es) Fenilalanina-amidas sustituidas por heteroaroilo .
ECSP055801A (es) Compuestos benzofuránicos, composiciones y métodos para el tratamiento y profilaxis de infecciones virales de hepatitis c y enfermedades asociadas
EP1499191A4 (en) REGULATED ATTENUATION OF LIVE VACCINES TO ENHANCE CROSS-PROTECTIVE IMMUNOGENICITY
BRPI0818672B8 (pt) composições, composições farmacêuticas e usos de 2'flúor-2'-desoxitetra-hidrouridinas
AR054251A1 (es) Vacuna de toxoide de c. perfringens alfa
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
UY30494A1 (es) Mimeticuerpos de glp-1 humanos, composiciones, métodos y usos
AR028948A1 (es) Compuestos novedosos
DOP2006000084A (es) Compuestos sulfoximino-macrociclicos y sus sales, composiciones farmaceuticas que comprenden dichos compuestos, metodos de preparacion y usos de los mismos
BRPI0513144A (pt) certos compostos de fosfato de glucosaminida de aminoalquila e seu uso
AR059772A1 (es) Composiciones que incuyen hemaglutinina metodos de elaboracion y metodos de uso de las mismas
CR9748A (es) Derivados de xantina como agonistas selectivos de hm74a
AR033800A1 (es) Derivados de 3-fenoxi-1-fenilacetileno sustituido, metodo para la preparacion de dichos derivados, composicion herbicida e inhibidora del crecimiento de las plantas, metodo para controlar el desarrollo de plantas perjudiciales, metodo para inhibir el desarrollo de plantas perjudiciales, y uso de dic
UY27851A1 (es) Difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
PA8576101A1 (es) Difenilazetidinonas sustituidas en grupo acido, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
ECSP088963A (es) Aminopirazolopiridinas sustituidas y sus sales, sus preparaciones y composiciones farmacéuticas que las comprenden
PA8587501A1 (es) Benzoxazinonas sustituidas y usos de las mismas
UY27852A1 (es) Difenilazatidinonas cationicamente sustituidas, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
CR9079A (es) Nonadepsipeptidos acilados como derivados de lisobactina
GT200400033A (es) Compuestos arilvinilazacicloalcano y metodos de preparacion y uso de ellos
AR041090A1 (es) Uso de toxina labil al calor de esterichia coli como adyuvante en pajaros y aves de corral

Legal Events

Date Code Title Description
FB Suspension of granting procedure